Vivo Capital VIII, LLC - Insider Non-Derivative Transactions at Terns Pharmaceuticals, Inc. (TERN) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Apr 3, 2024, Vivo Capital VIII, LLC's relationship to Terns Pharmaceuticals, Inc. (TERN) is TenPercentOwner, and currently has 4,023,741 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other TERN insiders.

Data Source: SEC.
Vivo Capital VIII, LLC - Insider Non-Derivative Transactions of TERN Common Stock
Apr 02Apr 03Apr 03Apr 0401M2M3M4M
Vivo Capital VIII, LLC - Insider Non-Derivative Transactions at TERN
Date
Transaction
No. of Shares
Price Per Share
Shares Owned After Transactions
Apr 4, 2024 Sell -- (Common Stock) 4,149 6.2 268,573
Apr 4, 2024 Sell -- (Common Stock) 30,047 6.2 1,945,015
Apr 4, 2024 Sell -- (Common Stock) 103,870 6.2 4,023,741
Apr 3, 2024 Sell -- (Common Stock) 3,050 6.65 272,722
Apr 3, 2024 Sell -- (Common Stock) 22,084 6.65 1,975,062
Apr 3, 2024 Sell -- (Common Stock) 76,346 6.65 4,127,611
Apr 2, 2024 Sell -- (Common Stock) 5,451 6.99 275,772
Apr 2, 2024 Sell -- (Common Stock) 39,411 6.99 1,997,146
Apr 2, 2024 Sell -- (Common Stock) 136,255 6.99 4,203,957
Items per page:
1 – 9 of 9